Dinda Adhia, Khairatul Qalbi, Kintan A Fannissa, Fajri Marindra


Background: At this time, Chronic Kidney Disease (CKD) is still a world health problem, CKD is usually undetected until it reaches the severe or terminal stage. CKD ranks 16th as a cause of death worldwide. Nationally, CKD has been the second largest expense following heart disease. This study was conducted to identify the symptoms and risk factors for chronic kidney disease in the elderly in social care institutions who are the population at risk. Methods: A descriptive study was conducted on 38 elderly people aged ≥60 years who are residents of nursing home 'X'. The residents of the nursing home who met the criteria of inclusion were interviewed and identified the risk factors and symptoms of CKD by conducting interviews using the available questionnaires and physical examination. Data were collected and presented in frequency distribution table. Results: from 38 respondents, 15 respondents had history of hypertension, 10 respondents had a history of diabetes mellitus, 16 respondents had history of smoking, 8 with history of NSAIDS use, and no one has history of kidney disease. The highest count of risk factor was found in 1 respondent (2.6%), meanwhile respondent with 1 and 2 risk factors was found in 11 respondents (28.9%). The most frequent symptom of CKD that appeared among respondents was decreased libido which 26 respondents experienced every day and the rarest symptom of kidney disease that appeared among respondents were restless legs which 35 respondents have never experienced. Conclusion: Almost every respondent had risk factor/s of CKD with the most frequent distribution of risk factor is 1-2 risk factor/s in one respondent and the most frequent symptom among respondents is impotence/decreased libido.


Save to Mendeley


CKD; geriatric; risk factor; symptom

Full Text:



Ahmad, M. et al. (2009) ‘Impact of renal transplantation on erectile

dysfunction due to chronic renal failure in male patients.’, Journal of

Ayub Medical College, Abbottabad : JAMC. Pakistan, 21(1), pp. 69–71.

Almutary, H., Bonner, A. and Douglas, C. (2013) ‘Symptom burden in chronic kidney disease: a review of recent literature.’, Journal of renal care. United States, 39(3),pp. 140–150. doi: 10.1111/j.1755-6686.2013.12022.x.

Bae, E. H. et al. (2019) ‘Association between systolic and diastolic blood

pressure variability and the risk of end-stage renal disease’, Hypertension, 74(4), pp. 880–887.

Brown, S. A. et al. (2017) ‘Symptom burden in patients with chronic

kidney disease not requiring renal replacement therapy’, Clinical

Kidney Journal, 10(6), pp. 788–796. doi: 10.1093/ckj/sfx057.

Center of Disease Control (2013) Anthropometry Procedures Manual,

National Health and Nutrition Examination Survey (NHANES). Atlanta.

Centers for Disease Control and Prevention (2019) Chronic kidney

disease in the United States. Atlanta, GA: US Department of Health and

Human Services, Centers for Disease Control and Prevention.

Chang, T. I. et al. (2020) ‘Associations of systolic blood pressure with incident CKD G3-G5: a cohort study of South Korean adults’, American Journal of Kidney Diseases, 76(2), pp. 224–232.

Chonchol, M. and Kendrick, J. (2015) ‘The patient with chronic

kidney disease’, in Schrier RW, ed. Manual of Nephrology. 8th ed.

Wolters Kluwer. Global Burden of Disease Collaborative Network

(2018) Global Burden of Disease Study 2017 (GBD 2017) All-cause

Mortality and Life Expectancy 1950-2017. Seattle, United State: Institue

for Health Metrics and Evaluation (IHME).

Hashimoto, Y. et al. (2015) ‘Metabolically healthy obesity and

risk of incident CKD’, Clinical Journal of the American Society of

Nephrology, 10(4), pp. 578–583.

Hervinda, S., Novadian, N. and Tjekyan, S. (2014) ‘Prevalensi dan

faktor risiko penyakit ginjal kronik di RSUP Dr. Mohammad Hoesin

Palembang’, Majalah Kedokteran Sriwijaya, 46(4), pp. 275–281.

Hsu, C. C. et al. (2015) ‘Use of nonsteroidal anti-inflammatory

drugs and risk of chronic kidney disease in subjects with

hypertension: nationwide longitudinal cohort study’, Hypertension, 66(3), pp. 524–533.

Indrayanti, S. et al. (2019) ‘Risk factors for chronic kidney disease: a

case-control study in a district hospital in Indonesia’, Journal of Pharmaceutical Sciences and Research, 11(7), pp. 2549–2554.

Ingsathit, A. et al. (2010) ‘Prevalence and risk factors of

chronic kidney disease in the Thai adult population: Thai SEEK study’,

Nephrology Dialysis Transplantation, 25(5), pp. 1567–1575.

Isfeedvajani, M. S. (2018) ‘Diabetes mellitus type 2 screening

guidelines’, International Journal of Medical Reviews, 5(4), pp. 137–139.

Jhamb, M. et al. (2013) ‘Prevalence and correlates of fatigue in chronic kidney disease and end-stage renal disease: are sleep disorders a key to understanding fatigue?’, American journal of nephrology, 38(6), pp.489–495. doi: 10.1159/000356939.

Kazancioğlu, R. (2013) ‘Risk factors for chronic kidney disease: an

update’, Kidney International Supplements, 3(4), pp. 368–371. doi:


KDIGO (2013) ‘Clinical Practice Guideline for the Evaluation and

Management of Chronic Kidney Disease’. Available at: (Accessed: 21 August 2020).

Kovesdy, C. P. et al. (2017) ‘Obesity and kidney disease: hidden

consequences of the epidemic’, Kidney International, 91(2), pp. 260262.doi:10.1016/j.kint.2016.10.019.

Kurzhagen, J. T. et al. (2020) ‘AKI: an increasingly recognized risk

factor for CKD development and progression’, Journal of Nephrology, 33(6), pp. 1171–1187.

Lefebvre, C. et al. (2020) ‘Non-steroidal anti-inflammatory drugs in

chronic kidney disease: a systematic review of prescription practices and

use in primary care’, Clinical Kidney Journal, 13(1), pp. 63–71.

Levey, A. S. and Coresh, J. (2012) ‘Chronic kidney disease’, The Lancet. doi: 10.1016/S0140-6736(11)60178-5.

Mahaldar, A. R. (2014) ‘Restless leg syndrome in chronic kidney

disease’, Clinical Queries: Nephrology, 3(1), pp. 5–8. doi:

McMahon, G. M. et al. (2014) ‘Mid-Adulthood risk factor profiles for

CKD’, Journal of the American Society of Nephrology, 25(11), pp.2633–2641.

Mirrakhimov, A. E. (2012) ‘Obstructive sleep apnea and kidney

disease: is there any direct link?’, Sleep and Breathing, 16(4),

pp.1009–1016. doi: 10.1007/s11325-011-0624-8.

Moreh, E., Jacobs, J. M. and Stessman, J. (2010) ‘Fatigue, function, and mortality in older adults.’, The journals of gerontology. Series A, Biological sciences and medical sciences. United States, 65(8), pp. 887–895. doi:10.1093/gerona/glq064.

Nwankwo, E. A., Wudiri, W. W. and Akinsola, A. (2010) ‘Risk factors for

the development of chronic kidney disease among Nigerians with essential hypertension’, Journal of Medical Sciences. Asian Network

for Scientific Information, 7(4), pp. 579–584. doi:10.3923/jms.2007.579.584.

Patel, D., Steinberg, J. and Patel, P. (2018) ‘Insomnia in the Elderly: A

Review.’, Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 14(6), pp. 1017–1024. doi:


Pranandari, R. and Supadmi, W. (2015) ‘Faktor resiko gagal ginjal

kronik di unit hemodialisis rsud wates kulonprogo’, Majalah farmaseutik, 11(2), pp. 316–320.

Rezonzew, G. et al. (2012) ‘Nicotine exposure and the progression of

chronic kidney disease: role of the α7-nicotinic acetylcholine receptor’,

American Journal of Physiology-Renal Physiology, 303(2), pp. 304–312.

See, E. J. et al. (2019) ‘Long-term risk of adverse outcomes after acute

kidney injury: a systematic review and meta-analysis of cohort studies

using consensus definitions of exposure’, Kidney International, 95(1), pp. 160–172

Tan, L. H. et al. (2019) ‘Prevalence of Insomnia and Poor Sleep in

Patients with Chronic Kidney Disease: A Systematic Review’, Kidney International Reports. Elsevier Inc, 4(7), p. S117. doi: 10.1016/j.ekir.2019.05.301.

United States Renal Data System (2015) ‘2015 USRDS Annual Data

Report : CKD in the United States’, 1.

Wang, A. Y., Jardine, M. and Perkovic, V. (2014) ‘Kidney disease in diabetes’, in Managing Cardiovascular Complications in Diabetes. Oxford, UK: John Wiley & Sons, Ltd, pp. 58–86.

Whelton, P. K. et al. (2018) ‘Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary’, Journal of the American College of Cardiology, 71(19), pp. 2199–2269.

Wu, H. and Huang, J. (2018) ‘Drug-induced nephrotoxicity: pathogenic

mechanisms, biomarkers and prevention strategies’, Current Drug

Metabolism, 19(7), pp. 559–567.

Yacoub, R. et al. (2010) ‘Association between smoking and chronic kidney disease: a case control study’, BMC Public Health, 10(1), p. 731.



  • There are currently no refbacks.